Symprove is a unique, liquid formulation containing four strains of live and active bacteria. It is clinically proven by independent, medical trials to be effective for both IBS and IBD
Symprove is a water-based liquid supplement that contains four strains of live and active bacteria: L. rhamnosus, E. faecium, L. acidophilus, and L. plantarum. A healthy gut would normally contain all four of these bacteria. However, modern lifestyles and environmental influences mean more people are lacking these vital bacteria from their guts. Research is now showing an imbalance can lead to a number of health conditions and complications.
Taking Symprove reintroduces these bacteria to the digestive system and helps to restore the gut’s natural balance. Learn more about the gut's microbiome.
Independent clinical trials have proven that Symprove is effective in reducing symptoms for people with irritable bowel syndrome (IBS) and the inflammatory bowel disease (IBD) ulcerative colitis.
It is one of the few non-dairy live bacteria liquid formulations on the market.
The problem many probiotics face is getting live bacteria through the acidic, hostile conditions of the stomach. Many products available on the market trigger digestion when they reach the stomach, which can cause the bacteria to be killed off before it gets to where it’s needed.
As a water-based supplement Symprove transits through the stomach rapidly and doesn’t trigger digestion - so the bacteria gets into the intestines quickly, and alive, where they can get to work populating the gut with its thriving friendly cultures.
An independent study by Dr Simon Gaisford proved Symprove is ALIVE when it is enters the body, SURVIVES the transit through the stomach and THRIVES in the gut. None of the other seven products tested by Dr Gaisford passed these tests.
There are a lot of probiotics and supplements available on the market and as healthcare professionals it can be hard to identify which products will work for your patients.
Symprove is different from other products available because:
Symprove is based on an extract of germinated barley. Four varieties of probiotic bacteria are then added and the extract provides the perfect food for the bacteria to thrive.
The whole process of making Symprove takes place on site at our Surrey-based processing plant - from cultivating the strains of bacteria to shipping the product to our customers around the world. We have put in place very strict procedures, and use independent testers, to ensure every batch of Symprove contains the right bacteria in the right quantities.
When Symprove reaches its customers it has been rigorously tested and analysed three times by an independent Good Manufacturing Practices (GMP) laboratory. This testing identifies the four strains of bacteria present and that the levels meet, or exceed, our minimum requirements of 10 billion live activated colony forming units per 50ml. It also confirms there are no other bacteria or contaminants in the batch.
We also send samples to be tested to ensure Symprove is gluten free.
The probiotic market is flooded with choice for the consumer. But Symprove is one of the only products available backed by independent clinical trials carried out on the finished product itself.
These trials, which were conducted under strict medical conditions, cover:
Symprove contains four live, activated lactic acid bacteria strains. These are:
It also contains
Under UK law Symprove is considered a food supplement and must abide by the same regulations other manufacturers of food supplements in the UK adhere to.
These regulations stipulate that, despite having high quality clinical studies demonstrating Symprove’s unique efficacy for people with IBS and IBD, we are not allowed to mention the results on our commercial website aimed at the general public, or make health-related claims about Symprove to them.
We choose to abide by all of the legislation, even if it prevents us from openly discussing the clinical trials Symprove has been through.
Welcome to Symprove Holdings Limited scientific website.
To access this site, please confirm that you are a healthcare professional, scientist or journalist.